Dicot Pharma AB (FRA:KN0) Beta: N/A (As of Jun. 26, 2026)


FRA:KN0 Dicot Pharma AB FRA:KN0
23 GF Score
Price €0.01
! 2 Warning Signs
View Full Analysis

What is Dicot Pharma AB Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Dicot Pharma AB's Beta is Not available.

Dicot Pharma AB  (FRA:KN0) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Dicot Pharma AB Beta Related Terms

Dicot Pharma AB Beta Historical Data

* Premium members only.

The historical data trend for Dicot Pharma AB's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dicot Pharma AB Beta Chart

Dicot Pharma AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Dicot Pharma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:KN0
23GF Score
Dicot Pharma AB FRA:KN0
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dicot Pharma AB Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Dicot Pharma AB Business Description

Other Exchanges DICOT:SwedenKN0:Germany
Address S:t Olofsgatan 11A, Uppsala, SWE, SE 753 21
Dicot Pharma AB is developing a modern potency medicine that will treat erectile dysfunction and premature ejaculation than existing preparations. The business model involves evaluating industrial and financial partnerships during clinical development to bring LIB-01 to commercialization on the world market. The company's drug candidate LIB-01 has a longer duration of action and fewer side effects, and is also used in the treatment of erectile dysfunction and premature ejaculation.
23GF Score

Get the complete analysis for FRA:KN0

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.01
Price